F2 and pertussis: In the 1990s a pediatric recombinant pertussis vaccine containing only 5 μg of genetically-inactivated pertussis toxin (PTgen) (DTaP5gen) showed an efficacy similar to a pediatric vaccine containing 25 μg of chemically inactivated PT (PTchem) (DTaP25chem) [12].